Page 11 - Journal of Special Operations Medicine - Spring 2017
P. 11

MEDCOM Regulation, No. 40-50, Medical Services












































              Articles of Interest                               mosquitoes were previously nuisance pests. However,
                                                                 they now represent a potential threat in the spread of
              Analysis of the Appropriateness of Off-Label Antipsy-  viral diseases. The Aedes aegypti, Aedes albopictus, and
              chotic Use for Mental Health Indications in a Veteran   Culex species mosquitoes are endemic to the United
              Population—In this article by JT Painter et al. in Phar-  States and together may transmit a variety of viral
              macotherapy,  the  abstract  states:  “Study  Objective:  A   diseases of growing concern, including West Nile virus,
              substantial proportion of antipsychotic (AP) use in vet-  chikungunya, dengue fever, and  Zika virus. The Cen-
              erans is for nonapproved indications (i.e., off-label pre-  ters for Disease Control and Prevention (CDC) recom-
              scribing). Not all off-label use is necessarily detrimental   mend DEET as a first-line mosquito repellent, but for
              to patients, however, and in certain situations, off-label   patients refusing to use DEET or other conventional re-
              prescribing could be considered justifiable. The objec-  pellents, guidance is limited to any EPA-registered prod-
              tive of this study was to determine the extent to which   uct.  Therefore,  we  conducted  a  systematic  review  of
              off-label AP prescribing in a veteran population was po-  the literature to identify which EPA-registered personal
              tentially appropriate. . . . Conclusion: The consensus of   mosquito repellent provides the best protection from
              our expert panel was that off-label AP use is dubious at   A. aegypti, A. albopictus, and Culex spp. mosquitoes.
              best and more likely, even in complicated cases, inap-  We abstracted data from 62 published reports of
              propriate. These findings strengthen the case for stron-  EPA-registered mosquito repellents. The conventional
              ger control of APs in integrated health care settings such   repellent  picaridin has the strongest data to support
              as the VHA, as well as better education and informa-  its use as a second-line agent, while IR3535 and oil of
              tion for practitioners who provide care for patients with   lemon eucalyptus are reasonably effective natural prod-
              anxiety, dementia, insomnia, or posttraumatic stress dis-  ucts. Citronella, catnip, and 2-undecanone offer limited
              order.”2017 Feb 5. doi: 10.1002/phar.1910.
                                                                 protection or have limited data. These results can be
                                                                 used by pharmacists and other health care professionals
              EPA-Registered  Repellents  for  Mosquitoes  Transmit-  to advise patients on the selection of an EPA-registered
              ting Emerging Viral Disease—Patel RV et al. presents in
              Pharmcotherapy: “In many parts of the United States,                            (continues on page 152)



              News To Use                                                                                     vii
   6   7   8   9   10   11   12   13   14   15   16